<DOC>
	<DOC>NCT01170169</DOC>
	<brief_summary>This study examines the bioequivalence of Dr. Reddy's Omeprazole delayed release capsules under fasting condition.</brief_summary>
	<brief_title>Omeprazole Delayed Release (DR) Capsules Bioequivalence Study of Dr. Reddys Under Fasting Conditions</brief_title>
	<detailed_description>This is a randomized, two-treatment, two-period, two-sequence, single dose, crossover bioequivalence study to compare Omeprazole 40 mg Delayed Release Capsules (Dr.Reddy's Laboratories Ltd.,) with Prilosec® 40 mg (Omeprazole Delayed Release Capsules (manufactured by Merck &amp; Co., Inc., USA) in 44 healthy, adult, human subjects under fasting conditions.</detailed_description>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Subjects who provided written informed consent. Subjects who were healthy within 1845 years of age, weighing at least 50 kg. Body mass index of ≥ 18 kglm2 and ≤ 25 kg/m2, with body weight not less than 50 kg. Subjects with normal health as determined by medical history and physical examination performed within 15 days prior to the commencement of the study (dosing in periodI). Subjects with normal ECG, chest Xray (PA view) and vital signs. Availability of subject for the entire study period and willingness to adhere to protocol requirements as evidenced by written informed consent. Test product, dose, mode of administration and batch number</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2010</verification_date>
</DOC>